The Dental and Pharmaceutical Benefits Agency (TLV) planned a theme survey on products for the diagnosis or treatment of lung cancer and colorectal cancer as part of the horizon scanning phase of the Orderly Introduction framework. The purpose of the theme survey is to identify products that may be relevant for health economic assessments at TLV within this framework.
This Orderly Introduction framework, which aims to manage the national introduction of novel technologies, is permanent from the beginning of 2020. This is a staged process, including horizon scanning, selection of the method for evaluation, the decision on national collaboration, health economic evaluation, and recommendations by the MTP Council to regions about the introduction of the method and criteria for use.
The theme survey is planned to be carried out in September – October 2022. However, no further information has been provided yet.
More details can be found in Swedish here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.